CHARLES SCHWAB INVESTMENT MANAGEMENT INC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 54 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$135,000
-23.3%
100,653
-35.3%
0.00%
Q4 2018$176,000
-45.2%
155,518
+33.8%
0.00%
Q3 2018$321,000
-67.4%
116,211
-57.8%
0.00%
-100.0%
Q2 2018$984,000
+27.0%
275,630
+9.2%
0.00%0.0%
Q1 2018$775,000
-49.6%
252,293
+3.5%
0.00%0.0%
Q4 2017$1,537,000
+3.5%
243,869
+12.3%
0.00%0.0%
Q3 2017$1,485,000
+60.5%
217,079
+67.4%
0.00%0.0%
Q2 2017$925,000
-21.9%
129,681
+0.7%
0.00%0.0%
Q1 2017$1,184,000
+142.6%
128,807
+6.5%
0.00%0.0%
Q4 2016$488,000
+11.7%
120,941
+6.2%
0.00%0.0%
Q3 2016$437,000
-10.5%
113,857
+0.4%
0.00%0.0%
Q2 2016$488,000
-5.6%
113,453
+1.7%
0.00%0.0%
Q1 2016$517,000
-52.9%
111,605
+2.1%
0.00%0.0%
Q4 2015$1,097,000
+11.4%
109,361
-17.1%
0.00%0.0%
Q3 2015$985,000
-64.0%
131,973
+128.9%
0.00%
-75.0%
Q2 2015$2,736,000
+73.6%
57,653
+34.1%
0.00%
+100.0%
Q1 2015$1,576,000
+6.1%
43,000
+15.0%
0.00%0.0%
Q4 2014$1,486,000
+130.4%
37,400
+15.8%
0.00%
+100.0%
Q3 2014$645,000
+47.9%
32,3000.0%0.00%0.0%
Q2 2014$436,000
+75.8%
32,300
+42.3%
0.00%
Q1 2014$248,000
+11.7%
22,700
+38.4%
0.00%
Q4 2013$222,000
+14.4%
16,4000.0%0.00%
Q3 2013$194,000
+61.7%
16,4000.0%0.00%
Q2 2013$120,00016,4000.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2013
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 354,300$7,068,0002.77%
Opaleye Management Inc. 169,700$3,385,515,0002.64%
Broadfin Capital, LLC 959,247$19,137,0002.01%
Novo Holdings A/S 900,000$17,955,0001.75%
Eventide Asset Management 300,900$6,003,0000.84%
EAM Investors, LLC 152,595$3,044,0000.62%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 497,858$9,932,0000.51%
Granite Point Capital Management, L.P. 40,000$798,0000.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,191$8,981,0000.33%
TFS CAPITAL LLC 133,070$2,655,0000.23%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders